Selected research
Industry Growth & Trends
Global C5a Anaphylatoxin Chemotactic Receptor 1 Industry Growth and Trends Forecast to 2032
Market perspective
The global C5a Anaphylatoxin Chemotactic Receptor 1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for C5a Anaphylatoxin Chemotactic Receptor 1 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for C5a Anaphylatoxin Chemotactic Receptor 1 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for C5a Anaphylatoxin Chemotactic Receptor 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of C5a Anaphylatoxin Chemotactic Receptor 1 include AFFiRiS AG, ChemoCentryx, Inc., Dompe Farmaceutici S.p.A. and Noxxon Pharma AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global C5a Anaphylatoxin Chemotactic Receptor 1 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The C5a Anaphylatoxin Chemotactic Receptor 1 market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global C5a Anaphylatoxin Chemotactic Receptor 1 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to C5a Anaphylatoxin Chemotactic Receptor 1.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global C5a Anaphylatoxin Chemotactic Receptor 1 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
C5a Anaphylatoxin Chemotactic Receptor 1 Market by Company
AFFiRiS AG
ChemoCentryx, Inc.
Dompe Farmaceutici S.p.A.
Noxxon Pharma AG
C5a Anaphylatoxin Chemotactic Receptor 1 Segment by Type
NOXD-20
NOXD-19
EP-67
DF-2593A
Others
C5a Anaphylatoxin Chemotactic Receptor 1 Segment by Application
Allergic Asthma
Huntington Disease
Acute Pain
Kidney Disease
Others
C5a Anaphylatoxin Chemotactic Receptor 1 Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C5a Anaphylatoxin Chemotactic Receptor 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of C5a Anaphylatoxin Chemotactic Receptor 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C5a Anaphylatoxin Chemotactic Receptor 1.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of C5a Anaphylatoxin Chemotactic Receptor 1 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of C5a Anaphylatoxin Chemotactic Receptor 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- NOXD-20
- NOXD-19
- EP-67
- DF-2593A
- Others
Applications
- Allergic Asthma
- Huntington Disease
- Acute Pain
- Kidney Disease
- Others
Companies covered
- AFFiRiS AG
- ChemoCentryx, Inc.
- Dompe Farmaceutici S.p.A.
- Noxxon Pharma AG
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Estimates and Forecasts (2021-2032)
- 1.3 C5a Anaphylatoxin Chemotactic Receptor 1 Market by Type
- 1.3.1 NOXD-20
- 1.3.2 NOXD-19
- 1.3.3 EP-67
- 1.3.4 DF-2593A
- 1.3.5 Others
- 1.4 Global C5a Anaphylatoxin Chemotactic Receptor 1 Market Size by Type
- 1.4.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Market Size Overview by Type (2021-2032)
- 1.4.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global C5a Anaphylatoxin Chemotactic Receptor 1 Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America C5a Anaphylatoxin Chemotactic Receptor 1 Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe C5a Anaphylatoxin Chemotactic Receptor 1 Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Sales Breakdown by Type (2021-2026)
- 1.5.4 South America C5a Anaphylatoxin Chemotactic Receptor 1 Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa C5a Anaphylatoxin Chemotactic Receptor 1 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 C5a Anaphylatoxin Chemotactic Receptor 1 Industry Trends
- 2.2 C5a Anaphylatoxin Chemotactic Receptor 1 Industry Drivers
- 2.3 C5a Anaphylatoxin Chemotactic Receptor 1 Industry Opportunities and Challenges
- 2.4 C5a Anaphylatoxin Chemotactic Receptor 1 Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by C5a Anaphylatoxin Chemotactic Receptor 1 Revenue (2021-2026)
- 3.2 Global Top Players by C5a Anaphylatoxin Chemotactic Receptor 1 Sales (2021-2026)
- 3.3 Global Top Players by C5a Anaphylatoxin Chemotactic Receptor 1 Price (2021-2026)
- 3.4 Global C5a Anaphylatoxin Chemotactic Receptor 1 Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global C5a Anaphylatoxin Chemotactic Receptor 1 Major Company Production Sites & Headquarters
- 3.6 Global C5a Anaphylatoxin Chemotactic Receptor 1 Company, Product Type & Application
- 3.7 Global C5a Anaphylatoxin Chemotactic Receptor 1 Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 C5a Anaphylatoxin Chemotactic Receptor 1 Players Market Share by Revenue in 2025
- 3.8.3 2025 C5a Anaphylatoxin Chemotactic Receptor 1 Tier 1, Tier 2, and Tier 3
4 C5a Anaphylatoxin Chemotactic Receptor 1 Regional Status and Outlook
- 4.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Historic Market Size by Region
- 4.2.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales in Volume by Region (2021-2026)
- 4.2.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales in Value by Region (2021-2026)
- 4.2.3 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global C5a Anaphylatoxin Chemotactic Receptor 1 Forecasted Market Size by Region
- 4.3.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales in Volume by Region (2027-2032)
- 4.3.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales in Value by Region (2027-2032)
- 4.3.3 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 C5a Anaphylatoxin Chemotactic Receptor 1 by Application
- 5.1 C5a Anaphylatoxin Chemotactic Receptor 1 Market by Application
- 5.1.1 Allergic Asthma
- 5.1.2 Huntington Disease
- 5.1.3 Acute Pain
- 5.1.4 Kidney Disease
- 5.1.5 Others
- 5.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Market Size by Application
- 5.2.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Market Size Overview by Application (2021-2032)
- 5.2.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global C5a Anaphylatoxin Chemotactic Receptor 1 Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America C5a Anaphylatoxin Chemotactic Receptor 1 Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe C5a Anaphylatoxin Chemotactic Receptor 1 Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Sales Breakdown by Application (2021-2026)
- 5.3.4 South America C5a Anaphylatoxin Chemotactic Receptor 1 Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa C5a Anaphylatoxin Chemotactic Receptor 1 Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 AFFiRiS AG
- 6.1.1 AFFiRiS AG Company Information
- 6.1.2 AFFiRiS AG Business Overview
- 6.1.3 AFFiRiS AG C5a Anaphylatoxin Chemotactic Receptor 1 Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 AFFiRiS AG C5a Anaphylatoxin Chemotactic Receptor 1 Product Portfolio
- 6.1.5 AFFiRiS AG Recent Developments
- 6.2 ChemoCentryx, Inc.
- 6.2.1 ChemoCentryx, Inc. Company Information
- 6.2.2 ChemoCentryx, Inc. Business Overview
- 6.2.3 ChemoCentryx, Inc. C5a Anaphylatoxin Chemotactic Receptor 1 Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 ChemoCentryx, Inc. C5a Anaphylatoxin Chemotactic Receptor 1 Product Portfolio
- 6.2.5 ChemoCentryx, Inc. Recent Developments
- 6.3 Dompe Farmaceutici S.p.A.
- 6.3.1 Dompe Farmaceutici S.p.A. Company Information
- 6.3.2 Dompe Farmaceutici S.p.A. Business Overview
- 6.3.3 Dompe Farmaceutici S.p.A. C5a Anaphylatoxin Chemotactic Receptor 1 Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Dompe Farmaceutici S.p.A. C5a Anaphylatoxin Chemotactic Receptor 1 Product Portfolio
- 6.3.5 Dompe Farmaceutici S.p.A. Recent Developments
- 6.4 Noxxon Pharma AG
- 6.4.1 Noxxon Pharma AG Company Information
- 6.4.2 Noxxon Pharma AG Business Overview
- 6.4.3 Noxxon Pharma AG C5a Anaphylatoxin Chemotactic Receptor 1 Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Noxxon Pharma AG C5a Anaphylatoxin Chemotactic Receptor 1 Product Portfolio
- 6.4.5 Noxxon Pharma AG Recent Developments
7 North America by Country
- 7.1 North America C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country
- 7.1.1 North America C5a Anaphylatoxin Chemotactic Receptor 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country (2021-2026)
- 7.1.3 North America C5a Anaphylatoxin Chemotactic Receptor 1 Sales Forecast by Country (2027-2032)
- 7.2 North America C5a Anaphylatoxin Chemotactic Receptor 1 Market Size by Country
- 7.2.1 North America C5a Anaphylatoxin Chemotactic Receptor 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America C5a Anaphylatoxin Chemotactic Receptor 1 Market Size by Country (2021-2026)
- 7.2.3 North America C5a Anaphylatoxin Chemotactic Receptor 1 Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country
- 8.1.1 Europe C5a Anaphylatoxin Chemotactic Receptor 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country (2021-2026)
- 8.1.3 Europe C5a Anaphylatoxin Chemotactic Receptor 1 Sales Forecast by Country (2027-2032)
- 8.2 Europe C5a Anaphylatoxin Chemotactic Receptor 1 Market Size by Country
- 8.2.1 Europe C5a Anaphylatoxin Chemotactic Receptor 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe C5a Anaphylatoxin Chemotactic Receptor 1 Market Size by Country (2021-2026)
- 8.2.3 Europe C5a Anaphylatoxin Chemotactic Receptor 1 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country
- 9.1.1 Asia-Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Market Size by Country
- 9.2.1 Asia-Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country
- 10.1.1 South America C5a Anaphylatoxin Chemotactic Receptor 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country (2021-2026)
- 10.1.3 South America C5a Anaphylatoxin Chemotactic Receptor 1 Sales Forecast by Country (2027-2032)
- 10.2 South America C5a Anaphylatoxin Chemotactic Receptor 1 Market Size by Country
- 10.2.1 South America C5a Anaphylatoxin Chemotactic Receptor 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America C5a Anaphylatoxin Chemotactic Receptor 1 Market Size by Country (2021-2026)
- 10.2.3 South America C5a Anaphylatoxin Chemotactic Receptor 1 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country
- 11.1.1 Middle East and Africa C5a Anaphylatoxin Chemotactic Receptor 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa C5a Anaphylatoxin Chemotactic Receptor 1 Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa C5a Anaphylatoxin Chemotactic Receptor 1 Market Size by Country
- 11.2.1 Middle East and Africa C5a Anaphylatoxin Chemotactic Receptor 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa C5a Anaphylatoxin Chemotactic Receptor 1 Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa C5a Anaphylatoxin Chemotactic Receptor 1 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 C5a Anaphylatoxin Chemotactic Receptor 1 Value Chain Analysis
- 12.1.1 C5a Anaphylatoxin Chemotactic Receptor 1 Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 C5a Anaphylatoxin Chemotactic Receptor 1 Production Mode & Process
- 12.2 C5a Anaphylatoxin Chemotactic Receptor 1 Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 C5a Anaphylatoxin Chemotactic Receptor 1 Distributors
- 12.2.3 C5a Anaphylatoxin Chemotactic Receptor 1 Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst